BERLIN--(Marketwired - August 29, 2013) - MagForce AG /
Voluntary Directors' Dealings announcement of Dr. Ben J. Lipps
. Ad hoc announcement according to § 15 WpHG. Processed and
transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
MagForce AG (Frankfurt, Entry Standard,
XETRA: MF6), a leading medical device company in the field of
focused on oncology, announced today that Ben Lipps, designated CEO
September 1st, 2013, has disclosed to the Company that he has bought
shares in MagForce, which represents 1.05% of the Company's outstanding
About MagForce AG
MagForce AG is a leading medical device company in the field of
oncology, listed in the entry standard (MF6). The Company's
NanoTherm® therapy, enables the targeted treatment of solid tumors
intratumoral generation of heat via activation of
nanoparticles. NanoTherm®, NanoPlan®, and NanoActivator™ are
of the therapy and have received EU-wide regulatory approval as medical
for the treatment of brain tumors. MagForce, NanoTherm®,
NanoActivator™ are trademarks of MagForce AG in selected countries. For
information, please visit www.magforce.com.
This release may contain forward-looking statements and information which
identified by formulations using terms such as "expects", "aims",
"intends", "plans", "believes", "seeks", "estimates" or "will". Such
forward-looking statements are based on our current expectations
assumptions, which may be subject to a variety of risks and
results actually achieved by MagForce AG may substantially differ from
forward-looking statements. MagForce AG assumes no obligation to update
forward-looking statements or to correct them in case of developments,
differ from those, anticipated.
MagForce_Press Release_August 29, 2013:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: MagForce AG via Thomson Reuters ONE